By targeting pathways such as ‘Degradation of Superoxide,’ ‘Thyroid hormone synthesis,’ and the ‘Mitochondrial Electron Transport Chain,’ treatment strategies can be refined to mitigate the underlying metabolic disturbances characteristic of PCOS. This evidence concerns the gene TG and polycystic ovary syndrome.